Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2002
06/27/2002WO2002050038A1 Dichloropyridyl methylamine for use as plant protecting agents
06/27/2002WO2002050033A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
06/27/2002WO2002050032A1 Naphthalene derivatives which bind to the ep4 receptor
06/27/2002WO2002050031A1 Indole derivatives
06/27/2002WO2002050030A2 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
06/27/2002WO2002049993A2 High affinity small molecule c5a receptor modulators
06/27/2002WO2002049648A1 Heteroaryl urea neuropeptide y y5 receptor antagonists
06/27/2002WO2002034746A3 Tridentate ligands and relative complexes with transition metals
06/27/2002WO2002030353A3 NF-λB INHIBITORS
06/27/2002WO2002022602A3 Triazole compounds useful as protein kinase inhibitors
06/27/2002WO2002022592A3 Substituted urea neuropeptide y y5 receptor antagonists
06/27/2002WO2002009648A3 Antimicrobial biaryl compounds
06/27/2002US20020082266 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
06/27/2002US20020082265 For treating or preventing emphysema, cancer and dermatological disorders
06/27/2002US20020082259 Triazine compounds
06/27/2002US20020082257 Elevates ATP binding cassette transporter 1 expression thereby increasing efflux of cholesterol from cells by active transfer into high density lipoproteins
06/27/2002US20020082256 Compounds useful as anti-inflammatory agents
06/27/2002DE10063868A1 Dichlorpyridincarbamide Dichlorpyridincarbamide
06/27/2002CA2431995A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
06/27/2002CA2431985A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
06/27/2002CA2431592A1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
06/27/2002CA2430808A1 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
06/26/2002EP1217000A1 Inhibitors of factor Xa and factor VIIa
06/26/2002EP1216285A1 Fluorescent maleimides and uses thereof
06/26/2002EP1216245A1 Pharmaceutically active sulfonyl hydrazide derivatives
06/26/2002EP1216244A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d 4? antagonists
06/26/2002EP1216241A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
06/26/2002EP1216240A1 Amide compounds
06/26/2002EP1216238A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
06/26/2002EP1216233A1 Quinazolinones
06/26/2002EP1216231A2 INHIBITORS OF FACTOR Xa
06/26/2002EP1216228A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
06/26/2002EP1049689B1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
06/26/2002EP0931067B1 D4 receptor selectivity piperazine derivatives
06/26/2002EP0929548B1 Substituted carbamoyl triazoles and their use as herbicides
06/26/2002EP0820441B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS
06/26/2002EP0650476B1 Peripheral vasodilating agent containing n-acylated 4-amino piperidine derivatives as active ingredients
06/26/2002CN1355811A Integrain receptor antagaonists
06/26/2002CN1086701C Chloropyridylcarbonyl derivative
06/26/2002CN1086700C Benzothiophene compounds, intermediates, composition, and methods
06/25/2002US6410791 Salbutamol; respiratory system disorders
06/25/2002US6410756 Family of Canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof
06/25/2002US6410740 Heterocyclylmethyl-substituted pyrazol derivatives
06/25/2002US6410586 Modulators of protein tyrosine phosphatases (PTPases)
06/25/2002US6410583 Prostaglandin antagonist
06/25/2002US6410582 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
06/25/2002US6410566 Cyclic amine derivatives and their use as drugs
06/25/2002US6410563 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
06/25/2002US6410562 Hypoglycemic imidazoline compounds
06/25/2002US6410561 Analgesics
06/25/2002US6410558 Using indole or quinoline compound
06/25/2002US6410540 Inhibitors of p38-αkinase
06/25/2002US6410529 Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists
06/20/2002WO2002048134A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
06/20/2002WO2002048124A2 Piperazine derivatives
06/20/2002WO2002048117A1 Quinazolinone derivatives
06/20/2002WO2002048112A2 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
06/20/2002WO2002048099A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/20/2002WO2002048081A1 Liquid crystalline compounds
06/20/2002WO2002048073A1 Method for producing compounds having a cf2o bridge
06/20/2002WO2002047762A1 Serine protease inhibitors
06/20/2002WO2002020495A3 Inhibitors of glycogen synthase kinase 3
06/20/2002US20020077486 Platelet ADP receptor inhibitors
06/20/2002US20020077483 Preparing a azole compound on a solid support resin, cleaving the compound from the solid support resin by nucleophilic substitution to further substituting by alkylation reaction
06/20/2002US20020077344 For therapy and prophylaxis of high blood pressure, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, cardiac infarct, vascular restenosis after angioplasty, cardiomyopathies, endothelial dysfunction
06/20/2002US20020077341 C10 carbamoyloxy substituted taxanes
06/20/2002US20020077338 HIV protease inhibitors
06/20/2002US20020077337 Chemical compounds
06/20/2002DE10063109A1 Dichlorpyridymethylimine Dichlorpyridymethylimine
06/20/2002DE10063008A1 Carbonsäureamidderivate Carboxamide
06/20/2002CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/20/2002CA2431406A1 Quinazolinone derivatives
06/20/2002CA2430992A1 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
06/19/2002EP1214322A2 Amino-triazolopyridine derivatives
06/19/2002EP1214316A1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
06/19/2002EP1214309A1 Preparing amidines derived from 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid
06/19/2002EP1214303A1 Heterocyclic compounds and methods of use thereof
06/19/2002EP0813528B1 Herbicidal or fungicidal sulphonylaminocarbonyltriazolinones with halogenated alk(en)oxy substituents
06/19/2002CN1086387C N-(aryloxyalkyl)heteroarylpiperidines and heteroarylpiperazines, their preparing method and their use as medicine
06/19/2002CN1086386C Multi-drug resistance modifier
06/18/2002US6407136 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
06/18/2002US6407103 Potent enzyme inhibitors of cyclin-dependent kinases relating to the catalytic subunits cdk1-9 and their regulatory subunits cyclins a-h; antiproliferative, -carcinogenic and -tumor agents; viricides; modulators of dna/rna biosynthesis
06/18/2002US6407102 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
06/18/2002US6407094 Glutamate receptor antagonists
06/18/2002US6407093 (3,4-dihydro-2h-benzothiopyran-4-yl)-homopiperazine derivatives; antiischemic agents; alzheimer*s and parkinson*s disease, aids related dementia, multiple sclerosis, amyotrophic lateral sclerosis
06/18/2002US6407087 UCF116 derivatives
06/18/2002US6407080 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
06/18/2002US6407041 Substituted 2,4-diamino-1,3,5-triazines
06/18/2002CA2238140C Imidazole, triazole and tetrazole derivatives
06/18/2002CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
06/13/2002WO2002046183A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
06/13/2002WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
06/13/2002WO2002046171A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
06/13/2002WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
06/13/2002WO2002046168A1 Therapeutic benzimidazole compounds
06/13/2002WO2002046164A1 Therapeutic compounds
06/13/2002WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
06/13/2002WO2002026706A3 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
06/13/2002WO2002024686A3 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives